Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025

Dosing regimens of (S)-1-(4-fluorophenyl)-1-(2-(4-(6-(1-methyl-1H-pyrazol-4-yl)pyrrolo[2,1-f][1,2,4]triazin-4-yl)piperazinyl)-pyrimidin-5-yl)ethan-1-amine for treatment of indolent systemic mastocytosis

US Patent 12252494 · Granted Mar 18, 2025

Assignee

Inventors

View full patent text on Google Patents →